Skip to content
healthcare.dev

KRAZATI

NDC 80739-812, adagrasib, tablet, coated, from Mirati Therapeutics, Inc.

Product NDC
80739-812
Status
Listed
Labeler
Mirati Therapeutics, Inc
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216340
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80739-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADAGRASIB200 mg/1
Package NDCNDC-11Package
80739-812-12807390812121 BOTTLE in 1 CARTON (80739-812-12) / 120 TABLET, COATED in 1 BOTTLE
80739-812-18807390812181 BOTTLE in 1 CARTON (80739-812-18) / 180 TABLET, COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0b8bf078-34c2-4f45-9012-38a8ac082b01

Use it

Look up 80739-812 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80739-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80739-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.